Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 28.42B | 28.61B | 28.70B | 28.22B | 24.61B | 17.30B |
Gross Profit | 15.28B | 15.50B | 14.92B | 14.32B | 12.95B | 7.15B |
EBITDA | 862.00M | -1.90B | 797.00M | 629.00M | -2.21B | -1.42B |
Net Income | 1.09B | -2.48B | 291.00M | 6.76B | -3.54B | -4.51B |
Balance Sheet | ||||||
Total Assets | 39.80B | 37.40B | 40.88B | 39.76B | 31.80B | 35.39B |
Cash, Cash Equivalents and Short-Term Investments | 4.08B | 7.88B | 5.38B | 13.55B | 5.47B | 7.72B |
Total Debt | 12.79B | 14.04B | 14.78B | 11.83B | 13.51B | 15.23B |
Total Liabilities | 24.88B | 25.20B | 26.24B | 25.26B | 24.09B | 24.77B |
Stockholders Equity | 14.24B | 11.54B | 13.98B | 13.86B | 7.05B | 9.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -338.00M | -12.44B | -691.00M | -1.27B | -337.00M |
Operating Cash Flow | 0.00 | 500.00M | -1.88B | 19.00M | -481.00M | 95.00M |
Investing Cash Flow | 0.00 | 2.80B | -7.90B | 10.22B | 132.00M | 5.58B |
Financing Cash Flow | 0.00 | -905.00M | 1.49B | -2.37B | -2.01B | -1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥25.28B | 10.74 | 4.63% | 13.23% | 16.74% | ||
80 Outperform | ¥22.57B | 8.70 | 3.30% | 0.64% | 25.69% | ||
73 Outperform | ¥18.54B | 6.97 | 4.98% | 17.29% | 5.46% | ||
72 Outperform | ¥23.60B | 18.03 | 6.44% | -9.16% | -42.30% | ||
69 Neutral | ¥30.31B | 9.80 | 3.62% | 8.60% | 93.71% | ||
62 Neutral | C$5.25B | 11.07 | 18.94% | 3.79% | 5.08% | 6.52% | |
53 Neutral | ¥24.74B | 20.34 | 10.39% | -0.31% | -850.70% |